Genovis AB (publ.)

Genovis AB (publ.)verified

GENO.ST

Price:

$20.5

Market Cap:

$1.35B

Genovis AB (publ.) designs, develops, and sells tools for development of drugs for customers in the pharmaceutical and medical device industries. The company offers FabALACTICA, a cysteine protease that digests human IgG1; FabRICATOR, an enzyme that primarily digests the hinge region of IgG; and FabRICATOR Z, an enzyme for the digestion of mouse IgG2a and IgG3, as well as for generating a homogenous pool of F(ab')2 and Fc fragments. It also provides FabULOUS (SpeB), an enzyme for the digestion of IgG in the hinge region; and GingisKHAN, a cysteine protease that digests human IgG1 at a specific site above the hinge. In addition, the company offers GingisREX, a cysteine protease that specifica...[Read more]

Industry

Biotechnology

IPO Date

2008-06-02

Stock Exchange

STO

Ticker

GENO.ST

The ROE as of December 2025 (TTM) for Genovis AB (publ.) (GENO.ST) is 8.80%

According to Genovis AB (publ.)’s latest financial reports and current stock price. The company's current ROE is 8.80%. This represents a change of 305.28% compared to the average of 2.17% of the last 4 quarters.

Genovis AB (publ.) (GENO.ST) Historical ROE (quarterly & annually)

How has GENO.ST ROE performed in the past?

The mean historical ROE of Genovis AB (publ.) over the last ten years is -26.11%. The current 8.80% ROE has changed -133.71% with respect to the historical average. Over the past ten years (40 quarters), GENO.ST's ROE was at its highest in in the March 2023 quarter at 25.63%. The ROE was at its lowest in in the March 2016 quarter at -63.10%.

Quarterly (TTM)
Annual

Average

-26.11%

Median

8.15%

Minimum

-225.64%

Maximum

32.23%

Genovis AB (publ.) (GENO.ST) ROE by Quarter and Year

Discovering the peaks and valleys of Genovis AB (publ.) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 261.89%

Maximum Annual ROE = 32.23%

Minimum Annual Increase = -508.74%

Minimum Annual ROE = -225.64%

Quarterly (TTM)
Annual
YearROEChange
202414.44%-55.20%
202332.23%261.89%
20228.91%-59.02%
202121.74%193.92%
20207.40%-72.42%
201926.81%-508.74%
2018-6.56%-84.99%
2017-43.71%-54.80%
2016-96.69%-57.15%
2015-225.64%49.24%

Genovis AB (publ.) (GENO.ST) Average ROE

How has GENO.ST ROE performed in the past?

The current ROE of Genovis AB (publ.) (GENO.ST) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

18.53%

5-year avg

16.94%

10-year avg

-26.11%

Genovis AB (publ.) (GENO.ST) ROE vs. Peers

How is GENO.ST’s ROE compared to its peers?

Genovis AB (publ.)’s ROE is greater than Diamyd Medical AB (publ) (-77.85%), less than Oncopeptides AB (publ) (9.01%), greater than SynAct Pharma AB (-54.05%), greater than BICO Group AB (publ) (-7.46%), less than Stille AB (5.85%), greater than OssDsign AB (publ) (-15.07%), less than Paxman AB (publ) (1.49%), less than I-Tech AB (25.10%), greater than Xspray Pharma AB (publ) (-36.36%), less than Cantargia AB (publ) (108.71%),

Build a custom stock screener for Genovis AB (publ.) (GENO.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genovis AB (publ.) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genovis AB (publ.) (GENO.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genovis AB (publ.) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Genovis AB (publ.)'s ROE?

How is the ROE calculated for Genovis AB (publ.) (GENO.ST)?

What is the highest ROE for Genovis AB (publ.) (GENO.ST)?

What is the 3-year average ROE for Genovis AB (publ.) (GENO.ST)?

What is the 5-year average ROE for Genovis AB (publ.) (GENO.ST)?

How does the current ROE for Genovis AB (publ.) (GENO.ST) compare to its historical average?